Literature DB >> 28579281

Interfractional variability of respiration-induced esophageal tumor motion quantified using fiducial markers and four-dimensional cone-beam computed tomography.

Peng Jin1, Maarten C C M Hulshof2, Niek van Wieringen2, Arjan Bel2, Tanja Alderliesten2.   

Abstract

PURPOSE: To investigate the interfractional variability of respiration-induced esophageal tumor motion using fiducial markers and four-dimensional cone-beam computed tomography (4D-CBCT) and assess if a 4D-CT is sufficient for predicting the motion during the treatment.
MATERIALS AND METHODS: Twenty-four patients with 63 markers visible in the retrospectively reconstructed 4D-CBCTs were included. For each marker, we calculated the amplitude and trajectory of the respiration-induced motion. Possible time trends of the amplitude over the treatment course and the interfractional variability of amplitudes and trajectory shapes were assessed. Further, the amplitudes measured in the 4D-CT were compared to those in the 4D-CBCTs.
RESULTS: The amplitude was largest in the cranial-caudal direction of the distal esophagus (mean: 7.1mm) and proximal stomach (mean: 7.8mm). No time trend was observed in the amplitude over the treatment course. The interfractional variability of amplitudes and trajectory shapes was limited (mean: ≤1.4mm). Moreover, small and insignificant deviation was found between the amplitudes quantified in the 4D-CT and in the 4D-CBCT (mean absolute difference: ≤1.0mm).
CONCLUSIONS: The limited interfractional variability of amplitudes and trajectory shapes and small amplitude difference between 4D-CT-based and 4D-CBCT-based measurements imply that a single 4D-CT would be sufficient for predicting the respiration-induced esophageal tumor motion during the treatment course.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  4D-CBCT; Esophageal cancer; Fiducial marker; Interfractional variability; Radiation therapy; Respiration-induced motion

Mesh:

Year:  2017        PMID: 28579281     DOI: 10.1016/j.radonc.2017.05.015

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  5 in total

1.  The use of tumour markers in oesophageal cancer to quantify setup errors and baseline shifts during treatment.

Authors:  Melissa Thomas; Robin De Roover; Schalk van der Merwe; Maarten Lambrecht; Gilles Defraene; Karin Haustermans
Journal:  Clin Transl Radiat Oncol       Date:  2020-11-05

2.  Tailoring four-dimensional cone-beam CT acquisition settings for fiducial marker-based image guidance in radiation therapy.

Authors:  Peng Jin; Niek van Wieringen; Maarten C C M Hulshof; Arjan Bel; Tanja Alderliesten
Journal:  J Med Imaging (Bellingham)       Date:  2018-01-12

3.  Review of MR-Guided Radiotherapy for Esophageal Cancer.

Authors:  Sangjune Laurence Lee; Michael Bassetti; Gert J Meijer; Stella Mook
Journal:  Front Oncol       Date:  2021-03-22       Impact factor: 6.244

4.  Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation.

Authors:  M R Boekhoff; R Bouwmans; P A H Doornaert; M P W Intven; J J W Lagendijk; A L H M W van Lier; M J A Rasing; S van de Ven; G J Meijer; S Mook
Journal:  Clin Transl Radiat Oncol       Date:  2022-03-17

5.  Predictive value of pediatric respiratory-induced diaphragm motion quantified using pre-treatment 4DCT and CBCTs.

Authors:  Sophie C Huijskens; Irma W E M van Dijk; Jorrit Visser; Brian V Balgobind; Coen R N Rasch; Tanja Alderliesten; Arjan Bel
Journal:  Radiat Oncol       Date:  2018-10-11       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.